These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16613655)

  • 1. Re-excision for ductal carcinoma in situ: the surgeon's least favorite operation.
    Ward BA; Latrenta L
    Cancer J; 2006; 12(1):14-6. PubMed ID: 16613655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nonpalpable breast cancer].
    Pushkarev SV; Dikovich MF; Adamian AT; Slonimskaia EM; Zobnina MN
    Vopr Onkol; 1992; 38(1):111-3. PubMed ID: 1338662
    [No Abstract]   [Full Text] [Related]  

  • 3. Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective.
    Newman LA
    J Natl Cancer Inst Monogr; 2010; 2010(41):152-7. PubMed ID: 20956822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ--management update.
    Stuart K; Boyages J; Brennan M; Ung O
    Aust Fam Physician; 2005 Nov; 34(11):949-54. PubMed ID: 16299630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999].
    Schwartz GF; Solin LJ; Olivotto IA; Ernster VL;
    Bull Cancer; 2000 Jun; 87(6):499-506. PubMed ID: 10903791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ductal carcinoma in situ of the breast].
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
    G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.
    Francis A; Fallowfield L; Rea D
    Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):6-8. PubMed ID: 25445552
    [No Abstract]   [Full Text] [Related]  

  • 9. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two breast carcinomas: ductal carcinoma in situ and lobular carcinoma in situ.
    Linton MJ
    Medsurg Nurs; 2013; 22(4):237-40. PubMed ID: 24147320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conservative treatment of ductal carcinoma in situ of the breast].
    Hepp R; Baeza MR
    Rev Med Chil; 1999 Nov; 127(11):1345-50. PubMed ID: 10835721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wire localisation biopsy of non-palpable breast lesions: reasons for unsuccessful excision.
    Kouskos E; Gui GP; Mantas D; Revenas K; Rallis N; Antonopoulou Z; Lampadariou E; Gogas H; Markopoulos C
    Eur J Gynaecol Oncol; 2006; 27(3):262-6. PubMed ID: 16800254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment selection in ductal carcinoma in situ.
    Morrow M; Schnitt SJ
    JAMA; 2000 Jan; 283(4):453-5. PubMed ID: 10659859
    [No Abstract]   [Full Text] [Related]  

  • 14. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
    Solin LJ
    J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
    [No Abstract]   [Full Text] [Related]  

  • 15. 1991 RSNA special focus session: current controversies in the management of ductal carcinoma in situ of the breast.
    Wilson JF; Destouet JM; Winchester DP; Kuske RR; Vogel VG
    Radiology; 1992 Oct; 185(1):77-81. PubMed ID: 1326120
    [No Abstract]   [Full Text] [Related]  

  • 16. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine ductal carcinoma in situ, comedo type, of the breast detected by screening mammography: a potentially pre-invasive counterpart of high grade neuroendocrine tumours.
    Kawasaki T; Inoue A; Mochizuki K; Inoue S; Nakazawa T; Kondo T; Yamane T; Niu D; Inoue M; Maruyama T; Oishi N; Katoh R
    Pathology; 2012 Apr; 44(3):273-5. PubMed ID: 22437750
    [No Abstract]   [Full Text] [Related]  

  • 18. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
    Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypofractionated radiation therapy for durable palliative treatment of bleeding, fungating breast cancers.
    Grewal AS; Freedman GM; Jones JA; Taunk NK
    Pract Radiat Oncol; 2019 Mar; 9(2):73-76. PubMed ID: 30665864
    [No Abstract]   [Full Text] [Related]  

  • 20. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.